Experience of the Father Following the Announcement of a First Pregnancy

April 9, 2018 updated by: Hospices Civils de Lyon
Experience of the father following the announcement of a first pregnancy Its context, immediate reactions and actions. Possible impact of this moment of life a few months or years later?

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Actual)

45

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • France
      • Beynost, France, 01700
        • Cabinet de médecine générale
      • Crémieu, France, 38460
        • Cabinet de médecine générale
      • Lyon, France, 69008
        • Cabinet de médecine générale
      • Vallon-Pont-d'Arc, France, 07150
        • Cabinet de médecine générale
      • Vaugneray, France, 69670
        • Cabinet de médecine générale

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 49 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)

Description

Inclusion Criteria:

- Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)

Exclusion Criteria:

  • Patients with severe or neurological psychiatric disorders inducing significant cognitive impairment
  • Patients who do not master the French language
  • Patients who cannot give free and informed consent (guardianship, curatorship, safeguard of justice ...)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Father
Male having been the father of at least one pregnancy whatever the outcome (pregnancy pursued, or abortion)
Behavioral: Interview by hierarchical evocation's Method
Interview to describe the experience of the man during the announcement of a pregnancy that it is expected or not.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Interview by hierarchical evocation's method
Time Frame: 30-45 minutes

Experience of the man during the announcement of a pregnancy that it is expected or not, without identification of an average answer, but description of the diversity of situations, contexts, felt, taken of decision and actions.

Since this study is observational and descriptive, it does not have a primary judgment criterion, the aim being to describe the studied population. However, according to the method of hierarchical evocation, it can be said that the average frequency of occurrence of the words and their average polarity index will be some outcome measure.
30-45 minutes

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 10, 2017

Primary Completion (Actual)

November 10, 2017

Study Completion (Actual)

November 10, 2017

Study Registration Dates

First Submitted

August 22, 2017

First Submitted That Met QC Criteria

August 22, 2017

First Posted (Actual)

August 24, 2017

Study Record Updates

Last Update Posted (Actual)

April 10, 2018

Last Update Submitted That Met QC Criteria

April 9, 2018

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL17_0073

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe